Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
(373)
Vaccaro, Olga
a
Masulli, Maria
a
Nicolucci, Antonio
b
Bonora, Enzo
c
Del Prato, Stefano
d
Maggioni, Aldo P
e
Rivellese, Angela A
a
Squatrito, Sebastiano
f
Giorda, Carlo B
g
Sesti, Giorgio
h
Mocarelli, Paolo
i
Lucisano, Giuseppe
b
Sacco, Michele
b
Signorini, Stefano
i
Cappellini, Fabrizio
i
Perriello, Gabriele
j
Babini, Anna Carla
k,at
Lapolla, Annunziata
l
Gregori, Giovanna
m,at
Giordano, Carla
n
Corsi, Laura
o,at
Buzzetti, Raffaella
p
Clemente, Gennaro
r
Di Cianni, Graziano
s
Iannarelli, Rossella
t
Cordera, Renzo
u
La Macchia, Olga
v
Zamboni, Chiara
w
Scaranna, Cristiana
x
Boemi, Massimo
y
Iovine, Ciro
a
Lauro, Davide
z
Leotta, Sergio
aa
Dall'Aglio, Elisabetta
ab
Cannarsa, Emanuela
ac
Tonutti, Laura
ad
Pugliese, Giuseppe
q
Bossi, Antonio C
ae
Anichini, Roberto
af
Dotta, Francesco
ag
Di Benedetto, Antonino
ah
Citro, Giuseppe
ai
Antenucci, Daniela
aj
Ricci, Lucia
g
Giorgino, Francesco
ak
Santini, Costanza
al
Gnasso, Agostino
h
De Cosmo, Salvatore
am
Zavaroni, Donatella
an
Vedovato, Monica
ao
Consoli, Agostino
ap
Calabrese, Maria
aq
di Bartolo, Paolo
ar
Fornengo, Paolo
as
Riccardi, Gabriele
a
D'Angelo, Federica
at
Giansanti, Roberto
at
Tanase, Laura
at
Lanari, Luigi
at
Testa, Ivano
at
Pancani, Francesca
at
Ranchelli, Anna
at
Vagheggi, Paolo
at
Scatona, Alessia
at
Fontana, Lucia
at
Laviola, Luigi
at
Tarantino, Lucia
at
Ippolito, Claudia
at
Gigantelli, Vittoria
at
Manicone, Mariangela
at
Conte, Eleonora
at
Trevisan, Roberto
at
Rota, Rossella
at
Dodesini, Alessandro R
at
Reggiani, Giulio Marchesini
at
Montesi, Luca
at
Mazzella, Natalia
at
Forlani, Gabriele
at
Caselli, Chiara
at
Di Luzio, Raffaella
at
Mazzotti, Arianna
at
Aiello, Antimo
at
Barrea, Angelina
at
Musto, Antonio
at
D'Amico, Fiorentina
at
Sinagra, Tiziana
at
Longhitano, Sara
at
Trowpea, Vanessa
at
Sparti, Maria
at
Italia, Salvatore
at
Lisi, Enrico
at
Grasso, Giuseppe
at
Pezzino, Vincenzo
at
Insalaco, Federica
at
Carallo, Claudio
at
Scicchitano, Caterina
at
De Franceschi, Maria Serena
at
Calbucci, Giovanni
at
Ripani, Raffaella
at
Cuneo, Giacomo
at
Corsi, Simona
at
Romeo, Francesco
at
Lesina, Annalisa
at
Comoglio, Marco
at
Bonetto, Caterina
at
Robusto, Anna
at
Nada, Elisa
at
Asprino, Vincenzo
at
Cetraro, Rosa
at
Impieri, Michelina
at
Lucchese, Giuseppe
at
Donnarumma, Giovanna
at
Tizio, Biagio
at
Lenza, Lazzaro
at
Paraggio, Pia
at
Tomasi, Franco
at
Dozio, Nicoletta
at
Scalambra, Egle
at
Mannucci, Edoardo
at
Lamanna, Caterina
at
Cignarelli, Mauro
at
Macchia, Olga La
at
Fariello, Stefania
at
Sorrentino, Maria Rosaria
at
Franzetti, Ivano
at
Radin, Raffaella
at
Annunziata, Francesca
at
Bonabello, Laura Affinito
at
Durante, Arianna
at
Dolcino, Mara
at
Gallo, Fiorenza
at
Mazzucchelli, Chiara
at
Aleo, Anna
at
Melga, Pierluigi
at
Briatore, Lucia
at
Maggi, Davide
at
Storace, Daniela
at
Cecoli, Francesca
at
D'Ugo, Ercole
at
Pupillo, Mario
at
Baldassarre, Maria Pompea Antonia
at
Salvati, Filippo
at
Minnucci, Anita
at
De Luca, Angelo
at
Zugaro, Antonella
at
Santarelli, Livia
at
Bosco, Angela
at
Petrella, Vittorio
at
La Verghetta, Grazia Giovanna
at
D'Andrea, Settimio
at
Giuliani, Anna Elisa
at
Polidoro, w Lorella
at
Sperandio, Alessandra
at
Sciarretta, Filomena
at
Pezzella, Alfonso
at
Carlone, Angela
at
Potenziani, Stella
at
Venditti, Chiara
at
Foffi, Chiara
at
Carbone, Salvatore
at
Cipolloni, Laura
at
Moretti, Chiara
at
Leto, Gaetano
at
Serra, Rosalia
at
Petrachi, Francesca
at
Romano, Isabella
at
Lacaria, Emilia
at
Russo, Laura
at
Goretti, Chiara
at
Sannino, Claudia
at
Dolci, Maria
at
Bruselli, Laura
at
Mori, Mary L
at
Baccetti, Fabio
at
Del Freo, Maria
at
Cucinotta, Domenico
at
Giunta, Loretta
at
Ruffo, Maria Concetta
at
Cannizzaro, Desiree
at
Pintaudi, Basilio
at
Perrone, Giovanni
at
Pata, Pietro
at
Ragonese, Francesco
at
Lettina, Gabriele
at
Mancuso, Teresa
at
Coppolino, Aldo
at
Piatti, Pier Marco
at
Monti, Lucilla
at
Stuccillo, Michela
at
Lucotti, Pietro
at
Setola, Manuela
at
Crippa, Giulia Valentina
at
Loi, Cinzia
at
Oldani, Matteo
at
Bottalico, Maria Luisa
at
Pellegata, Beatrice
at
Bonomo, Matteo
at
Menicatti, Laura Silvia Maria
at
Resi, Veronica
at
Bertuzzi, Federico
at
Disoteo, Eugenia Olga
at
Pizzi, Gianluigi
at
Annuzzi, Giovanni
at
Capaldo, Brunella
at
Nappo, Rossella
at
Auciello, Stefania Michela
at
Turco, Anna Amelia
at
Costagliola, Lucia
at
Corte, Giuseppina Della
at
Vallefuoco, Pasquale
at
Nappi, Francesca
at
Vitale, Marilena
at
Cocozza, Sara
at
Ciano, Ornella
at
Massimino, Elena
at
Garofalo, Nadia
at
Avogaro, Angelo
at
Guarneri, Gabriella
at
Fedele, Domenico
at
Sartore, Giovanni
at
Chilelli, Nino Cristiano
at
Burlina, Silvia
at
Bonsembiante, Barbara
at
Galluzzo, Aldo
at
Torregrossa, Vittoria
at
Mancastroppa, Giovanni
at
Arsenio, Leone
at
Cioni, Federico
at
Caronna, Silvana
at
Papi, Matteo
at
Santeusanio, Fausto
at
Calagreti, Gioia
at
Timi, Alessia
at
Tantucci, Alice
at
Marino, Cecilia
at
Ginestra, Federica
at
Di Biagio, Rosamaria
at
Taraborelli, Merilda
at
Miccoli, Roberto
at
Bianchi, Cristina
at
Garofolo, Monia
at
Politi, Konstantina Savina
at
Penno, Giuseppe
at
Livraga, Stefania
at
Calzoni, Fabio
at
Mancastroppa, Giovanni Luigi Francesco
at
Corsini, Elisa
at
Tedeschi, Anna
at
Gaglianò, Maria Sole
at
Ippolito, Giulio
at
Salutini, Elisabetta
at
Cervellino, Francesco
at
Natale, Maria
at
Salvatore, Vita
at
Zampino, Armando
at
Sinisi, Rosa
at
Arcangeli, Adolfo
at
Zogheri, Alessia
at
Guizzotti, Sandra
at
Longo, Rossella
at
Pellicano, Francesca
at
Scolozzi, Patrizia
at
Termine, Simona
at
Luberto, Alessandra
at
Ballardini, Giorgio
at
Trojani, Cristina
at
Mazzuca, Paolo
at
Bruglia, Matteo
at
Ciamei, Monica
at
Genghini, Silvia
at
Zannoni, Chiara
at
Rangel, Graziela
at
Salvi, Laura
at
Zappaterreno, Alessandra
at
Cordone, Samantha
at
Simonelli, Paola
at
Meggiorini, Marilla
at
Frasheri, Aurora
at
Di Pippo, Clelia
at
Maglio, Cristina
at
Mazzitelli, Giulia
at
Rinaldi, Maria Elena
at
Galli, Angelica
at
Romano, Maria
at
D'Angelo, Paola
at
Suraci, Concetta
at
Bacci, Simonetta
at
Palena, Antonio Pio
at
Genovese, Stefano
at
Mancino, Monica
at
Rondinelli, Maurizio
at
Capone, Filippo
at
Calabretto, Elisabetta
at
Bulgheroni, Monica
at
Bucciarelli, Loredana
at
Ceccarelli, Elena
at
Fondelli, Cecilia
at
Santacroce, Clorinda
at
Guarino, Elisa
at
Nigi, Laura
at
Lalli, Carlo
at
Di Vizia, Giovanni
at
Scarponi, Maura
at
Montani, Valeria
at
Di Bernardino, Paolo
at
Romagni, Paola
at
Dolcetti, Katia
at
Forte, Elisa
at
Tamburo, Lucilla
at
Perin, Paolo Cavallo
at
Prinzis, Tania
at
Gruden, Gabriella
at
Bruno, Graziella
at
Zucco, Chiara
at
Perotta, Massimo
at
Marena, Saverio
at
Monsignore, Simona
at
Panero, Francesco
at
Ponzi, Fulvia
at
Carpinteri, Rita
at
Casagrande, Maria Linda
at
Coletti, Maria Francesca
at
Balini, Annalisa
at
Filopanti, Marcello
at
Madaschi, Sara
at
Pulcina, Anna
at
Grimaldi, Franco
at
Venturini, Giorgio
at
Agus, Sandra
at
Pagnutti, Stefania
at
Guidotti, Francesca
at
Cavarape, Alessandro
at
Cigolini, Massimo
at
Pichiri, Isabella
at
Brangani, Corinna
at
Fainelli, Giulia
at
Tomasetto, Elena
at
Zoppini, Giacomo
at
Galletti, Anna
at
Perrone, Dominica
at
Capra, Claudio
at
Bianchini, Francesca
at
Ceseri, Martina
at
Di Nardo, Barbara
at
Sasso, Elisa
at
Bartolomei, Barbara
at
Suliman, Irina
at
Fabbri, Gianna
at
Romano, Geremia
at
Maturo, Nicola
at
Nunziata, Giuseppe
at
Capobianco, Giuseppe
at
De Simone, Giuseppina
at
Villa, Valeria
at
Rota, Giuseppe
at
Pentangelo, Carmine
at
Carbonara, Ornella
at
Caiazzo, Gennaro
at
Cutolo, Michele
at
Sorrentino, Tommasina
at
Mastrilli, Valeria
at
Amelia, Umberto
at
Masi, Stefano
at
Corigliano, Gerardo
at
Gaeta, Iole
at
Armentano, Vincenzo
at
Calatola, Pasqualino
at
Capuano, Gelsomina
at
Angiulli, Bruno
at
Auletta, Pasquale
at
Petraroli, Ettore
at
Iodice, Cinzia E
at
Agrusta, Mariano
at
more..
|
-
1
-
-
3142680168
-
Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial
-
Vaccaro, O, Eberly, LE, Neaton, JD, Yang, L, Riccardi, G, Stamler, J, for the Multiple Risk Factor Intervention Trial (MRFIT) Research Group. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 164 (2004), 1438–1443.
-
(2004)
Arch Intern Med
, vol.164
, pp. 1438-1443
-
-
Vaccaro, O.1
Eberly, L.E.2
Neaton, J.D.3
Yang, L.4
Riccardi, G.5
Stamler, J.6
-
2
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998), 837–853.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
3
-
-
53749091595
-
10-year follow-up of intensive glucose control in type 2 diabetes
-
Holman, RR, Paul, SK, Bethel, MA, Matthews, DR, Neil, HA, 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008), 1577–1589.
-
(2008)
N Engl J Med
, vol.359
, pp. 1577-1589
-
-
Holman, R.R.1
Paul, S.K.2
Bethel, M.A.3
Matthews, D.R.4
Neil, H.A.5
-
4
-
-
0032983666
-
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)
-
Turner, RC, Cull, CA, Frighi, V, Holman, RR, for the UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 281 (1999), 2005–2012.
-
(1999)
JAMA
, vol.281
, pp. 2005-2012
-
-
Turner, R.C.1
Cull, C.A.2
Frighi, V.3
Holman, R.R.4
-
5
-
-
84925489733
-
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Inzucchi, SE, Bergenstal, RM, Buse, JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 58 (2015), 429–442.
-
(2015)
Diabetologia
, vol.58
, pp. 429-442
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
-
6
-
-
33750469241
-
Standards of medical care in diabetes—2017
-
American Diabetes Association. Standards of medical care in diabetes—2017. Diabetes Care 40:suppl 1 (2017), S1–S135.
-
(2017)
Diabetes Care
, vol.40
, pp. S1-S135
-
-
-
7
-
-
85019196764
-
Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013
-
Lipska, KJ, Yao, X, Herrin, J, et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013. Diabetes Care 40 (2017), 468–475.
-
(2017)
Diabetes Care
, vol.40
, pp. 468-475
-
-
Lipska, K.J.1
Yao, X.2
Herrin, J.3
-
8
-
-
84978976076
-
Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis
-
Palmer, SC, Mavridis, D, Nicolucci, A, et al. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis. JAMA 316 (2016), 313–324.
-
(2016)
JAMA
, vol.316
, pp. 313-324
-
-
Palmer, S.C.1
Mavridis, D.2
Nicolucci, A.3
-
9
-
-
84928429195
-
Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer
-
Abdelmoneim, AS, Eurich, DT, Light, PE, et al. Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer. Diabetes Obes Metab 17 (2015), 523–532.
-
(2015)
Diabetes Obes Metab
, vol.17
, pp. 523-532
-
-
Abdelmoneim, A.S.1
Eurich, D.T.2
Light, P.E.3
-
10
-
-
26244453309
-
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
-
Dormandy, JA, Charbonnel, B, Eckland, DJA, et al., on behalf of the PROactive Investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 (2005), 1279–1289.
-
(2005)
Lancet
, vol.366
, pp. 1279-1289
-
-
Dormandy, J.A.1
Charbonnel, B.2
Eckland, D.J.A.3
-
11
-
-
84962114446
-
Pioglitazone after ischemic stroke or transient ischemic attack
-
Kernan, WN, Viscoli, CM, Furie, LH, et al., for the IRIS Trial Investigators. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med 374 (2016), 1321–1331.
-
(2016)
N Engl J Med
, vol.374
, pp. 1321-1331
-
-
Kernan, W.N.1
Viscoli, C.M.2
Furie, L.H.3
-
12
-
-
84938364689
-
Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes
-
Lewis, JD, Habel, LA, Quesenberry, CP, et al. Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes. JAMA 314 (2015), 265–277.
-
(2015)
JAMA
, vol.314
, pp. 265-277
-
-
Lewis, J.D.1
Habel, L.A.2
Quesenberry, C.P.3
-
13
-
-
84908564226
-
Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials
-
Zhu, NZ, Jang, YF, Ding, T, Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials. Bone 68 (2014), 115–123.
-
(2014)
Bone
, vol.68
, pp. 115-123
-
-
Zhu, N.Z.1
Jang, Y.F.2
Ding, T.3
-
14
-
-
84928803853
-
The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies
-
Lorenzo, CV, Margulis, A, Pladevall, M, et al. The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies. BMC Cardiovasc Disord, 14, 2014, 129.
-
(2014)
BMC Cardiovasc Disord
, vol.14
, pp. 129
-
-
Lorenzo, C.V.1
Margulis, A.2
Pladevall, M.3
-
15
-
-
85020727559
-
Revisiting the use of pioglitazone in the treatment of type 2 diabetes
-
Einhorn, D, Fonseca, V, Revisiting the use of pioglitazone in the treatment of type 2 diabetes. Endocr Pract 22 (2016), 1343–1346.
-
(2016)
Endocr Pract
, vol.22
, pp. 1343-1346
-
-
Einhorn, D.1
Fonseca, V.2
-
16
-
-
84868367261
-
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial
-
Vaccaro, O, Masulli, M, Bonora, E, et al., On behalf of the TOSCA.IT study group (Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents. Intervention Trial). Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. Nutr Metab Cardiovasc Dis 22 (2012), 997–1006.
-
(2012)
Nutr Metab Cardiovasc Dis
, vol.22
, pp. 997-1006
-
-
Vaccaro, O.1
Masulli, M.2
Bonora, E.3
-
17
-
-
85045679671
-
-
Associazione Medici Diabetologi (AMD), Società Italiana di Diabetologia (SID). Standard Italiani per la cura del diabete mellito, 2016, Edizioni Infomedica, Torino.
-
-
-
-
18
-
-
85045617699
-
-
European Medicines Agency. European Medicines Agency recommends new contraindications and warnings for pioglitazone to reduce small increased risk of bladder cancer. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2011/07/WC500109176.pdf, July 21, 2011 (accessed March 30, 2017).
-
-
-
-
19
-
-
25444474448
-
A review of methods for futility stopping based on conditional power
-
Lachin, JM, A review of methods for futility stopping based on conditional power. Stat Med 24 (2005), 2747–2764.
-
(2005)
Stat Med
, vol.24
, pp. 2747-2764
-
-
Lachin, J.M.1
-
20
-
-
84921350530
-
-
Singer, JD, Willett, JB, Applied longitudinal data analysis: modeling change and event occurrence, 2003, Oxford University Press, New York.
-
-
-
-
21
-
-
84946049571
-
Excess mortality in persons with type 2 diabetes
-
Tancredi, M, Rosengren, A, Svenson, A-M, et al. Excess mortality in persons with type 2 diabetes. N Engl J Med 373 (2015), 1720–1732.
-
(2015)
N Engl J Med
, vol.373
, pp. 1720-1732
-
-
Tancredi, M.1
Rosengren, A.2
Svenson, A.-M.3
-
22
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
-
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998), 854–865.
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
23
-
-
67149146438
-
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
-
Home, PD, Pocock, SJ, Beck-Nielsen, H, et al., for the RECORD Study Team. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 373 (2009), 2125–2135.
-
(2009)
Lancet
, vol.373
, pp. 2125-2135
-
-
Home, P.D.1
Pocock, S.J.2
Beck-Nielsen, H.3
-
24
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008), 2560–2572.
-
(2008)
N Engl J Med
, vol.358
, pp. 2560-2572
-
-
-
25
-
-
84927563050
-
Mortality risk among sulfonylureas: a systematic review and network meta-analysis
-
Simpson, SH, Lee, J, Choi, S, Vandermeer, B, Abdelmoneim, AS, Featherstone, TR, Mortality risk among sulfonylureas: a systematic review and network meta-analysis. Lancet Diabetes Endocrinol 3 (2015), 43–51.
-
(2015)
Lancet Diabetes Endocrinol
, vol.3
, pp. 43-51
-
-
Simpson, S.H.1
Lee, J.2
Choi, S.3
Vandermeer, B.4
Abdelmoneim, A.S.5
Featherstone, T.R.6
-
26
-
-
41649084422
-
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial
-
Nissen, SE, Nicholls, SJ, Wolski, K, et al., for the PERISCOPE Investigators. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 299 (2008), 1561–1573.
-
(2008)
JAMA
, vol.299
, pp. 1561-1573
-
-
Nissen, S.E.1
Nicholls, S.J.2
Wolski, K.3
-
27
-
-
84855512299
-
Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes
-
Sam, S, Haffner, S, Davidson, MH, D'Agostino, R Sr, Perez, A, Mazzone, T, Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes. J Clin Endocrinol Metab 97 (2012), E110–E114.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. E110-E114
-
-
Sam, S.1
Haffner, S.2
Davidson, M.H.3
D'Agostino, R.4
Perez, A.5
Mazzone, T.6
-
28
-
-
33845405222
-
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
-
Kahn, SE, Haffner, SM, Heise, MA, et al., for the ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 335 (2006), 2427–2443.
-
(2006)
N Engl J Med
, vol.335
, pp. 2427-2443
-
-
Kahn, S.E.1
Haffner, S.M.2
Heise, M.A.3
-
29
-
-
84901768284
-
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
-
Holman, RR, Sourij, H, Califf, RM, Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes. Lancet 383 (2014), 2008–2017.
-
(2014)
Lancet
, vol.383
, pp. 2008-2017
-
-
Holman, R.R.1
Sourij, H.2
Califf, R.M.3
-
30
-
-
84926475145
-
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA)
-
Marx, N, Rosenstock, J, Kahn, SE, et al. Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA). Diab Vasc Dis Res 12 (2015), 164–174.
-
(2015)
Diab Vasc Dis Res
, vol.12
, pp. 164-174
-
-
Marx, N.1
Rosenstock, J.2
Kahn, S.E.3
|